메뉴 건너뛰기




Volumn 36, Issue 3, 2009, Pages 331-337

Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CYANOCOBALAMIN; HEMOSIDERIN; INTERFERON BETA SERINE;

EID: 59149083168     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01019.x     Document Type: Article
Times cited : (21)

References (30)
  • 1
    • 0028258794 scopus 로고
    • How many people in the world have multiple sclerosis?
    • Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994 13 : 1.
    • (1994) Neuroepidemiology , vol.13 , pp. 1
    • Dean, G.1
  • 2
    • 34248365318 scopus 로고    scopus 로고
    • Combination therapies for multiple sclerosis: Scientific rationale, clinical trials, and clinical practice
    • review).
    • Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. Curr Opin Neurol 2007 20 : 281 (review).
    • (2007) Curr Opin Neurol , vol.20 , pp. 281
    • Costello, F.1    Stüve, O.2    Weber, M.S.3    Zamvil, S.S.4    Frohman, E.5
  • 3
    • 0033544299 scopus 로고    scopus 로고
    • Multiple sclerosis: Side effects of interferon beta therapy and their management
    • review).
    • Walther EU, Hohfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999 53 : 1622 (review).
    • (1999) Neurology , vol.53 , pp. 1622
    • Walther, E.U.1    Hohfeld, R.2
  • 4
    • 33845208781 scopus 로고    scopus 로고
    • Panniculitis and lipoatrophy after subcutaneous injection of interferon β-1b in a patient with multiple sclerosis
    • letter).
    • O'Sullivan SS, Cronin EM, Sweeney BJ, Bourke JF, Fitzgibbon J. Panniculitis and lipoatrophy after subcutaneous injection of interferon β-1b in a patient with multiple sclerosis. J Neurol Neurosurg Psychiatry 2006 77 : 1382 (letter).
    • (2006) J Neurol Neurosurg Psychiatry , vol.77 , pp. 1382
    • O'Sullivan, S.S.1    Cronin, E.M.2    Sweeney, B.J.3    Bourke, J.F.4    Fitzgibbon, J.5
  • 5
    • 0027418515 scopus 로고
    • Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
    • The IFNB Multiple Sclerosis Study Group.
    • The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993 43 : 655.
    • (1993) Neurology , vol.43 , pp. 655
  • 6
    • 0032494792 scopus 로고    scopus 로고
    • Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
    • European Study Group on interferon β-1b in secondary progressive MS.
    • European Study Group on interferon β-1b in secondary progressive MS. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis. Lancet 1998 352 : 1491.
    • (1998) Lancet , vol.352 , pp. 1491
  • 7
    • 0029161628 scopus 로고
    • Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
    • The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group.
    • The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995 45 : 1277.
    • (1995) Neurology , vol.45 , pp. 1277
  • 8
    • 0008376732 scopus 로고    scopus 로고
    • Interferon beta in the treatment of multiple sclerosis. Mechanisms of action
    • Yong VW, Chabot S, Stuve O, Williams G. Interferon beta in the treatment of multiple sclerosis. Mechanisms of action. Neurology 1998 51 : 682.
    • (1998) Neurology , vol.51 , pp. 682
    • Yong, V.W.1    Chabot, S.2    Stuve, O.3    Williams, G.4
  • 9
    • 0027946071 scopus 로고
    • Neutralizing interferon β antibodies in melanoma patients treated with recombinant and natural interferon β
    • Fierlbeck G, Schreiner T, Schaber B, Walser A, Rassner G. Neutralizing interferon β antibodies in melanoma patients treated with recombinant and natural interferon β. Cancer Immunol Immunother 1994 39 : 263.
    • (1994) Cancer Immunol Immunother , vol.39 , pp. 263
    • Fierlbeck, G.1    Schreiner, T.2    Schaber, B.3    Walser, A.4    Rassner, G.5
  • 10
    • 0347047191 scopus 로고    scopus 로고
    • Interferon beta-1b injection site reactions and necroses
    • Gaines AR, Varricchio F. Interferon beta-1b injection site reactions and necroses. Mult Scler 1998 4 : 70.
    • (1998) Mult Scler , vol.4 , pp. 70
    • Gaines, A.R.1    Varricchio, F.2
  • 11
    • 0030793925 scopus 로고    scopus 로고
    • Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum
    • Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol 1997 37 : 553.
    • (1997) J Am Acad Dermatol , vol.37 , pp. 553
    • Elgart, G.W.1    Sheremata, W.2    Ahn, Y.S.3
  • 12
    • 0042624739 scopus 로고    scopus 로고
    • Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFN β 1b
    • Casoni F, Merelli E, Bedin R, Martella A, Cesinaro A, Bertolotto A. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFN β 1b. Mult Scler 2003 9 : 420.
    • (2003) Mult Scler , vol.9 , pp. 420
    • Casoni, F.1    Merelli, E.2    Bedin, R.3    Martella, A.4    Cesinaro, A.5    Bertolotto, A.6
  • 13
    • 0033576097 scopus 로고    scopus 로고
    • Skin reactions to interferon beta in a series of 92 patients with multiple sclerosis
    • Spanish).
    • Fortuno Y, Marcoval J, Gallego I, Moreno A, Arbizu T, Peyri J. Skin reactions to interferon beta in a series of 92 patients with multiple sclerosis. Med Clin (Barc) 1999 113 : 447 (Spanish).
    • (1999) Med Clin (Barc) , vol.113 , pp. 447
    • Fortuno, Y.1    Marcoval, J.2    Gallego, I.3    Moreno, A.4    Arbizu, T.5    Peyri, J.6
  • 14
    • 0030994109 scopus 로고    scopus 로고
    • Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature
    • Weinberg JM, Wolfe JT, Sood S, Saruk M, Rook AH, Spiers EM. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature. Acta Derm Vernereol 1997 77 : 146.
    • (1997) Acta Derm Vernereol , vol.77 , pp. 146
    • Weinberg, J.M.1    Wolfe, J.T.2    Sood, S.3    Saruk, M.4    Rook, A.H.5    Spiers, E.M.6
  • 15
    • 0036177776 scopus 로고    scopus 로고
    • Cutaneous mucinoses complicating interferon beta-1b therapy
    • Benito-León J, Borbujo J, Cortés L. Cutaneous mucinoses complicating interferon beta-1b therapy. Eur Neurol 2002 47 : 123.
    • (2002) Eur Neurol , vol.47 , pp. 123
    • Benito-León, J.1    Borbujo, J.2    Cortés, L.3
  • 16
    • 23844552827 scopus 로고    scopus 로고
    • Abdominal wall ulceration and mucinosis secondary to recombinant human interferon- β-1b
    • Wells J, Kossard S, McGrath M. Abdominal wall ulceration and mucinosis secondary to recombinant human interferon- β-1b. Australas J Dermatol 2005 46 : 202.
    • (2005) Australas J Dermatol , vol.46 , pp. 202
    • Wells, J.1    Kossard, S.2    McGrath, M.3
  • 17
    • 36048986302 scopus 로고    scopus 로고
    • Lupus-like reaction to interferon at the injection site: Report of five cases
    • Arrue I, Saiz A, Ortiz-Romero PL, Rodriguez-Peralto JL. Lupus-like reaction to interferon at the injection site: report of five cases. J Cutan Pathol 2007 34 (Suppl. 1 18.
    • (2007) J Cutan Pathol , vol.341 , pp. 18
    • Arrue, I.1    Saiz, A.2    Ortiz-Romero, P.L.3    Rodriguez-Peralto, J.L.4
  • 18
    • 59149105872 scopus 로고    scopus 로고
    • Interferon beta injection site reaction: A lupus like histology
    • abstract).
    • Ferringer T, Sewell L, Miller O. Interferon beta injection site reaction: a lupus like histology. J Cutan Pathol 2008 35 : 166 (abstract).
    • (2008) J Cutan Pathol , vol.35 , pp. 166
    • Ferringer, T.1    Sewell, L.2    Miller, O.3
  • 19
    • 0031765912 scopus 로고    scopus 로고
    • Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injections
    • Mehta CL, Tyler RJ, Cripps DJ. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injections. J Am Acad Dermatol 1998 39 : 1024.
    • (1998) J Am Acad Dermatol , vol.39 , pp. 1024
    • Mehta, C.L.1    Tyler, R.J.2    Cripps, D.J.3
  • 20
    • 0036191371 scopus 로고    scopus 로고
    • Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient
    • Heinzerling L, Drummer R, Burg G, Schmid-Grenelmeier P. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol 2002 12 : 194.
    • (2002) Eur J Dermatol , vol.12 , pp. 194
    • Heinzerling, L.1    Drummer, R.2    Burg, G.3    Schmid-Grenelmeier, P.4
  • 21
    • 0031942959 scopus 로고    scopus 로고
    • Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon beta injection
    • German).
    • Ziegler VR, Kranke B, Soyer P, Aberer W. Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon beta injection. Hautarzt 1998 49 : 310 (German).
    • (1998) Hautarzt , vol.49 , pp. 310
    • Ziegler, V.R.1    Kranke, B.2    Soyer, P.3    Aberer, W.4
  • 22
    • 33644944164 scopus 로고    scopus 로고
    • Lipoatrophy: A non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis
    • letter).
    • Beiske AG, Myhr KM. Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis. J Neurol 2006 253 : 377 (letter).
    • (2006) J Neurol , vol.253 , pp. 377
    • Beiske, A.G.1    Myhr, K.M.2
  • 23
    • 84861573415 scopus 로고    scopus 로고
    • Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. a report of 2 cases
    • Online early articles]. Available at. accessed 22 November 2007).
    • Ball NJ, Cowan BJ, Moore GRW, Hashimoto SA. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of 2 cases. 2007. J Cutan Pathol Online early articles]. Available at http://www.blackwell-synergy.com/toc/up/0/0 (accessed 22 November 2007).
    • (2007) J Cutan Pathol
    • Ball, N.J.1    Cowan, B.J.2    Moore, G.R.W.3    Hashimoto, S.A.4
  • 25
    • 0005489101 scopus 로고    scopus 로고
    • Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b. Experience during the first three years
    • The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group.
    • The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b. Experience during the first three years. Neurology 1996 47 : 889.
    • (1996) Neurology , vol.47 , pp. 889
  • 27
    • 0030024417 scopus 로고    scopus 로고
    • Possible origin of pancreatic fat necrosis as a septal panniculitis
    • Ball NJ, Adams SPA, Marx LH, Enta T. Possible origin of pancreatic fat necrosis as a septal panniculitis. J Am Acad Dermatol 1996 34 : 362.
    • (1996) J Am Acad Dermatol , vol.34 , pp. 362
    • Ball, N.J.1    Adams, S.P.A.2    Marx, L.H.3    Enta, T.4
  • 29
    • 25844482090 scopus 로고    scopus 로고
    • Subcutaneous interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction
    • Buttmann M, Goebeler M, Toksoy A, et al. Subcutaneous interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction. J Neuroimmunol 2005 168 : 175.
    • (2005) J Neuroimmunol , vol.168 , pp. 175
    • Buttmann, M.1    Goebeler, M.2    Toksoy, A.3
  • 30
    • 0021265575 scopus 로고
    • Studies on safety problem by skin tests using human beta interferon preparation
    • Muranaka M, Suzuki S. Studies on safety problem by skin tests using human beta interferon preparation. J Interferon Res 1984 4 : 115.
    • (1984) J Interferon Res , vol.4 , pp. 115
    • Muranaka, M.1    Suzuki, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.